Fernando Araujo was named Chief Financial Officer of TransMedics Group, Inc., effective September 21, 2026. As of November 6, 2026, TransMedics Group, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on September 10, 2026, naming 2 appointments (Form 8-K, September 10, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like TransMedics Group, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
TransMedics Group, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-10. It names 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as TransMedics Group, Inc. files it.
Also on the record for TransMedics Group, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.06% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.68% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| July 18, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 14.6% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs TransMedics Group, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on TransMedics Group, Inc. and the records around it.
TransMedics Group, Inc. elsewhere on the record
Companies that share a holder
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch TransMedics Group, Inc.
Get an email when TransMedics Group, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on TransMedics Group, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TransMedics Group, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TransMedics Group, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-10 | In | Chief Financial Officer | 2026-09-21 | 8-K, 2026-09-10 | |
| 2026-09-10 | In | 8-K, 2026-09-10 |
Who leads TransMedics Group, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Fernando Araujo, appointed, effective 2026-09-21 (filed 2026-09-10).
New leaders reset buying decisions — get the Full Report on TransMedics Group, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at TransMedics Group, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at TransMedics Group, Inc.Every change, in the filing's words
Appointed: Fernando Araujo, Chief Financial Officer, effective 2026-09-21
On September 10, 2026, the Board of Directors (the "Board") of TransMedics Group, Inc. (the "Company") appointed Fernando Araujo as Chief Financial Officer and Treasurer, effective as of September 21, 2026.
Appointed: Gerardo Hernandez
From the Separation Date until April 30, 2027, Mr. Hernandez will serve as a non-employee senior advisor to the Company.
- Mr. Araujo will succeed Gerardo Hernandez, who has served as the Company's Chief Financial Officer since 2024.
- Fernando Araujo, age 46, will serve as Chief Financial Officer and Treasurer effective September 21, 2026.
- Prior to joining TransMedics, from 2023 to 2026, Mr. Araujo served as Chief Financial Officer for GE Health Care's Advanced Imaging Solutions (a combination of GE Health Care's Imaging and Advanced Visualization Solutions businesses and associated global integrated Supply Chain and Global Service organizations).
- Before joining GE HealthCare, Mr. Araujo served as Senior Vice President, Finance at 3M Enterprise Operations from October 2022 to March 2023.
- Prior to that he held various roles at GE, including Chief Financial Officer, Healthcare US and Canada and Chief Financial Officer, Healthcare Latin America from March 2018 to October 2022.
- Mr. Araujo holds a Bachelor of Business Administration from Centro Universitario UNA and an MBA from Columbia Business School.
Tools for this story
Each opens in a new tab, filled in for TransMedics Group, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.